Topics:

Rheumatoid Arthritis

New Biologics at EULAR 2014: Stop, or Wait?

A German rheumatologist attending the European Union League Against Rheumatism's annual meeting in Paris took progress notes on new biologics-in-testing. What's moving ahead and what's stalled? He provides a chart with a handy visual key.

Rheumatoid Arthritis

herpes zoster

People who have rheumatoid or psoriatic arthritis or lupus are at increased risk for shingles. Studies suggest that treatment for the rheumatic condition may be a factor in certain circumstances.

Backed by 6 drug firms and 4 foundations, the National Institutes of Health has created a large network of top researchers charged wtih collaborating to comprehend lupus and rheumatoid arthritis at the cellular and molecular level.

Chronic fatigue in rheumatoid arthritis is common, has been compared to that in cancer, and is not resolved by treating inflammation. But there are ways to assess and address it.

Joshua Baker MD

(AUDIO) Rheumatoid arthritis patients with low or normal body mass index have a greater risk of progression on X-ray or MRI, according to a large study.

The B-cell depleter tabalumab proved effective in a long-term trial, but only after its maker had stopped development for rheumatoid arthritis.

A large study of veterans reveals factors that predict which people starting methotrexate for rheumatic diseases after the age of 65 will quickly begin to show signs of liver damage.

Being overweight or obese not only increases the risk of rheumatoid arthritis developing in the first place; it also makes RA worse and decreases chances for remission.

Pages

Subscribe to Rheumatoid Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.